svg-arrow-next svg-arrow-prev
×

Order online: 0917-565-3700/ 0998-530-3700

sidebar

Insulin Degludec + Insulin Aspart

RYZODEG

Ryzodeg Flextouch 100U/mL 3mL

(No reviews) Write a Review
₱1,153.00

SKU:
027036
Generic Name:
Insulin Degludec + Insulin Aspart


Note: Uploaded prescription slip is subject to validation by our Pharmacist.

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

Ryzodeg Flextouch 100U/mL 3mL

₱1,153.00

Ryzodeg Flextouch 100U/mL 3mL

₱1,153.00

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.

An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.

PRODUCT DETAILS  
   
Brand Name Ryzodeg® FlexTouch®
Generic Name Insulin degludec/Insulin aspart 70/30
Strength 1 ml contains 100 units (equivalent to 2.56 mg insulin degludec and 1.05 mg insulin aspart)
Dosage Form Solution for injection in pre-filled pen
Indication/Usage Treatment of diabetes mellitus in adults, adolescents and children from the age of 2 years.
Dosage and Administration Can be administered once or twice daily with the main meal(s). When needed, the patient can change the time of administration as long as Ryzodeg® is dosed with the largest meal when taken once daily.
Initiation: Patients with type 2 diabetes mellitus - The recommended total daily starting dose is 10 units with meal(s) followed by individual dosage adjustments. Patients with type 1 diabetes mellitus - The recommended starting dose of Ryzodeg® is 60–70% of the total daily insulin requirements. Ryzodeg® is to be used once daily at mealtime in combination with short-/rapid-acting insulin at the remaining meals followed by individual dosage adjustments.
Transfer from other insulin products: Close glucose monitoring is recommended during the transfer and in the following weeks.
Special Populations (with glucose monitoring): Can be used in the elderly (≥ 65 years old). Can be used in renal and hepatic impaired patients. Can be used in adolescents and children from the age of 2 years, with special caution in children 2 to 5 years old. For subcutaneous use only.
Warning and Precautions Hypoglycaemia may result from omission of a meal or unplanned strenuous physical exercise, and may occur if the insulin dose is too high in relation to the insulin requirement. Hyperglycaemia may result from inadequate dosing and/or discontinuation of treatment in patients requiring insulin. products. Transferring a patient to another type, brand or manufacturer of insulin must be done under medical supervision and may result in the need for a change in dosage. Cases of cardiac failure have been reported when thiazolidinediones and insulin medicinal products are used in combination. Temporary worsening of diabetic retinopathy associated with intensification of insulin therapy. Avoid accidental mix-ups between Ryzodeg® and other insulin products. Formation of insulin antibodies upon administration of insulin.
Contraindication Hypersensitivity to the active substances or to any of the excipients.
Requires prescription? Yes
Storage Conditions Before first use: Store in a refrigerator (2°C
– 8°C). Do not freeze. After first opening or carried as a spare: The
product may be stored for a maximum of 4 weeks. Do not store
above 30°C. Can be stored in a refrigerator (2°C – 8°C).
Manufacturer Novo Nordisk A/S
Regulatory Classification Prescription

Related Products

Be a member